CIP
TECH icon

Champlain Investment Partners’s Bio-Techne TECH Stock Holding History

Champlain Investment Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76M Buy
1,454,171
+50,402
+4% +$3.03M 0.96% 48
2025
Q4 		$82.6M Sell
1,403,769
-298,474
-18% -$18.1M 0.84% 56
2025
Q3 		$94.7M Sell
1,702,243
-963,441
-36% -$51.6M 0.71% 59
2025
Q2 		$137M Buy
2,665,684
+217,362
+9% +$10.9M 0.96% 40
2025
Q1 		$144M Buy
2,448,322
+28,668
+1% +$1.94M 1.04% 31
2024
Q4 		$174M Sell
2,419,654
-186,765
-7% -$13.7M 1.1% 27
2024
Q3 		$208M Sell
2,606,419
-70,895
-3% -$5.33M 1.26% 28
2024
Q2 		$192M Sell
2,677,314
-67,460
-2% -$4.96M 1.18% 28
2024
Q1 		$193M Sell
2,744,774
-31,345
-1% -$2.24M 1.11% 27
2023
Q4 		$214M Buy
2,776,119
+83,810
+3% +$5.52M 1.27% 22
2023
Q3 		$183M Buy
2,692,309
+561,800
+26% +$44.4M 1.19% 23
2023
Q2 		$174M Buy
2,130,509
+239,875
+13% +$19.3M 1.07% 34
2023
Q1 		$140M Sell
1,890,634
-29,125
-2% -$2.24M 0.88% 42
2022
Q4 		$159M Sell
1,919,759
-16,261
-0.8% -$1.29M 1.02% 31
2022
Q3 		$137M Sell
1,936,020
-38,360
-2% -$3.31M 0.94% 38
2022
Q2 		$171M Sell
1,974,380
-15,440
-0.8% -$1.45M 1.11% 29
2022
Q1 		$215M Buy
1,989,820
+294,020
+17% +$30.3M 1.12% 26
2021
Q4 		$219M Buy
1,695,800
+126,632
+8% +$15.5M 0.99% 34
2021
Q3 		$190M Sell
1,569,168
-211,792
-12% -$25.8M 0.91% 39
2021
Q2 		$200M Sell
1,780,960
-555,120
-24% -$58.4M 0.95% 37
2021
Q1 		$223M Sell
2,336,080
-752,560
-24% -$68.7M 1.16% 27
2020
Q4 		$245M Sell
3,088,640
-638,300
-17% -$46.2M 1.41% 18
2020
Q3 		$231M Buy
3,726,940
+103,980
+3% +$6.76M 1.57% 15
2020
Q2 		$239M Sell
3,622,960
-761,860
-17% -$45.6M 1.72% 14
2020
Q1 		$208M Buy
4,384,820
+914,120
+26% +$45.7M 1.87% 8
2019
Q4 		$190M Buy
3,470,700
+143,260
+4% +$7.52M 1.39% 25
2019
Q3 		$163M Buy
3,327,440
+418,660
+14% +$21M 1.34% 26
2019
Q2 		$152M Buy
2,908,780
+28,420
+1% +$1.43M 1.27% 29
2019
Q1 		$143M Buy
2,880,360
+47,960
+2% +$2.16M 1.25% 28
2018
Q4 		$102M Buy
2,832,400
+455,860
+19% +$19M 1.04% 39
2018
Q3 		$121M Buy
2,376,540
+308,360
+15% +$13.7M 1.08% 35
2018
Q2 		$76.5M Buy
+2,068,180
New +$79M 0.74% 61
2013
Q4 		– Sell
-986,300
Closed -$19.7M – 134
2013
Q3 		$19.7M Sell
986,300
-920,920
-48% -$17.5M 0.37% 99
2013
Q2 		$32.9M Buy
+1,907,220
New +$31.7M 0.67% 62

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Champlain Investment Partners's TECH Position: Q1 2026 in Review

Champlain Investment Partners increased its Bio-Techne (TECH) stake by 3.6% in Q1 2026, buying an estimated $3.03M and bringing the position to 1,454,171 shares worth $76M. The position accounts for 0.96% of the portfolio, ranked #48.

Champlain Investment Partners first reported a position in TECH in Q2 2013 and has held it in 34 quarters since. The position peaked at $245M in Q4 2020. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Champlain Investment Partners held 1,454,171 shares of Bio-Techne worth $76M as of Q1 2026.
  • Champlain Investment Partners bought 50,402 Bio-Techne shares in Q1 2026, an estimated $3.03M.
  • Bio-Techne made up 0.96% of Champlain Investment Partners's portfolio in Q1 2026, its #48 holding.
  • Champlain Investment Partners first reported a position in Bio-Techne in Q2 2013 and has held it in 34 quarters since.
  • Champlain Investment Partners's Bio-Techne position peaked at $245M in Q4 2020.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.